Literature DB >> 9274637

The scleroatrophic syndrome of Huriez.

G M Kavanagh1, P E Jardine, R D Peachey, J C Murray, D De Berker.   

Abstract

We have examined 14 of 28 members of a four-generation family, 10 of whom demonstrated the clinical features of the scleroatrophic syndrome of Huriez, a cancer-prone dermatosis. Several members of this family demonstrated additional features, previously unrecorded in this syndrome, including poikiloderma-like changes on the nose, flexion contractures of the little finger, a distinctive little finger nodule, and telangiectasia on the lips. Genetic linkage was excluded to distal chromosome 4q (LOD score-4.399 at theta = 0.001). This concurs with the recent reappraisal study of one of the two original families described by Huriez, in which no evidence of linkage between this syndrome and the MNSs erythrocytic system (mapped to 4q28-q31) was found. This is the first report of a family from the U.K. with this syndrome.

Entities:  

Mesh:

Year:  1997        PMID: 9274637

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q23.

Authors:  Y A Lee; H P Stevens; E Delaporte; U Wahn; A Reis
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Mal de meleda with lip involvement: a report of two cases.

Authors:  Amiya Kumar Nath; Sangita Chaudhuri; Devinder Mohan Thappa
Journal:  Indian J Dermatol       Date:  2012-09       Impact factor: 1.494

3.  A novel mutation in TRPV3 gene causes atypical familial Olmsted syndrome.

Authors:  Cheng Ni; Ming Yan; Jia Zhang; Ruhong Cheng; Jianying Liang; Dan Deng; Zhen Wang; Ming Li; Zhirong Yao
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

Review 4.  Type I Interferon Induction in Cutaneous DNA Damage Syndromes.

Authors:  Benjamin Klein; Claudia Günther
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.